Back
Seelos Therapeutics Stock Price Chart
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Sell
7
SEEL
Seelos Therapeutics
Last Price:
0.20
Seasonality Move:
-10.79%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SEEL is experiencing slight selling pressure.
Seelos Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.2 | Buy |
| 20-day SMA: | 0.24 | Sell |
| 50-day SMA: | 0.34 | Sell |
| 200-day SMA: | 4.46 | Sell |
| 8-day EMA: | 0.21 | Sell |
| 20-day EMA: | 0.24 | Sell |
| 50-day EMA: | 0.48 | Sell |
| 200-day EMA: | 24.4 | Sell |
Seelos Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 37.06 | Sell |
| Chaikin Money Flow: | -107058 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.2 - 0.34) | Sell |
| Bollinger Bands (100): | (0.14 - 1.56) | Sell |
Seelos Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Seelos Therapeutics Stock
Is Seelos Therapeutics Stock a Buy?
- Seelos Therapeutics share price is 0.20 while SEEL 8-day simple moving average is 0.20, which is a Buy signal.
- The stock price of SEEL is 0.20 while Seelos Therapeutics 20-day SMA is 0.24, which makes it a Sell.
- Seelos Therapeutics 50-day simple moving average is 0.34 while SEEL share price is 0.20, making it a Sell technically.
- SEEL stock price is 0.20 and Seelos Therapeutics 200-day simple moving average is 4.46, creating a Sell signal.
SEEL Technical Analysis vs Fundamental Analysis
Sell
7
Seelos Therapeutics (SEEL)
is a Sell
Is Seelos Therapeutics a Buy or a Sell?
-
Seelos Therapeutics stock is rated a Sell
The current Seelos Therapeutics [SEEL] share price is $0.20. The Score for SEEL is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
Seelos Therapeutics Stock Info
Market Cap:
1.42M
Price in USD:
0.20
Share Volume:
724.22K
Seelos Therapeutics 52-Week Range
52-Week High:
57.58
52-Week Low:
0.18
Sell
7
Seelos Therapeutics (SEEL)
is a Sell
Seelos Therapeutics Share Price Forecast
-
What is the Seelos Therapeutics stock price today?
The Seelos Therapeutics stock price is 0.20 USD today. -
Will SEEL stock go up or go down?
Seelos Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Seelos Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Seelos Therapeutics is overvalued.
Is Seelos Therapeutics Stock a Buy?
- Seelos Therapeutics share price is 0.20 while SEEL 8-day exponential moving average is 0.21, which is a Sell signal.
- The stock price of SEEL is 0.20 while Seelos Therapeutics 20-day EMA is 0.24, which makes it a Sell.
- Seelos Therapeutics 50-day exponential moving average is 0.48 while SEEL share price is 0.20, making it a Sell technically.
- SEEL stock price is 0.20 and Seelos Therapeutics 200-day simple moving average is 24.40, creating a Sell signal.
Fundamental Analysis of Seelos Therapeutics
Is Seelos Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $16.80 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Seelos Therapeutics
Should I short Seelos Therapeutics stock?
- SEEL Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting Seelos Therapeutics is a Sell
- Seelos Therapeutics Relative Strength Index (RSI) is 37.06, which suggest Seelos Therapeutics is oversold
- The Bollinger Bands (25) for Seelos Therapeutics is (0.2 - 0.34), which suggest Seelos Therapeutics is a Sell
- The Bollinger Bands (100) for Seelos Therapeutics is (0.14 - 1.56), which suggest Seelos Therapeutics is a Sell
* Seelos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.